Department of Pharmacology, Third Faculty of Medicine, Charles University of Prague, Ruska 87, 100 34, Prague, Czech Republic.
Naunyn Schmiedebergs Arch Pharmacol. 2009 Jun;379(6):575-80. doi: 10.1007/s00210-009-0402-3. Epub 2009 Feb 11.
The aim of the study was to ascertain antinociceptive effects of rilmenidine, a second-generation imidazoline-alpha-2-adrenoreceptor agonist, and to see whether rilmenidine was able to increase the analgesic effects of paracetamol in the writhing test in mice. An acetic acid (0.7%) solution was injected into the peritoneal cavity and the number of writhes was counted. The influence on locomotor performance was tested using the rotarod test. Rilmenidine, paracetamol, and rilmenidine-paracetamol fixed-ratio combinations produced dose-dependent antinociceptive effects. ED(50) values were estimated for the individual drugs and an isobologram was constructed. The derived theoretical additive ED(50) value for the rilmenidine-paracetamol combination was 109.23 +/- 35.05 mg/kg. This value was significantly greater than the observed ED(50) value which was 56.35 +/- 20.86 mg/kg, indicating a synergistic interaction. Rilmenidine did not impair motor coordination, as measured by the rotarod test, at antinociceptive and higher doses.
本研究旨在确定第二代咪唑啉-α2-肾上腺素受体激动剂利美尼定的镇痛作用,并观察利美尼定是否能增加扑热息痛在小鼠扭体试验中的镇痛作用。将 0.7%的乙酸溶液注入腹腔,计数扭体次数。采用旋转棒试验测试对运动性能的影响。利美尼定、扑热息痛和利美尼定-扑热息痛固定比例组合产生剂量依赖性镇痛作用。估算了各药物的 ED50 值,并构建了等效应线图。利美尼定-扑热息痛组合的理论相加 ED50 值为 109.23 +/- 35.05 mg/kg。该值明显大于观察到的 ED50 值 56.35 +/- 20.86 mg/kg,表明存在协同作用。利美尼定在镇痛和更高剂量下,通过旋转棒试验测量,并未损害运动协调能力。